Drug intelligence / Profile preview

wenshen-huatan-quyu

Development stage: Preclinical
Lead developer: Shanghai Science and Technology Commission Guiding Project

Overview

Wenshen-Huatan-Quyu is a traditional Chinese medicine (TCM) particle formulation. Its name translates to "warming kidney, resolving phlegm, and dispelling blood stasis," indicating its therapeutic principles within TCM. It is being investigated in a randomized controlled trial in combination with valsartan for the treatment of benign hypertensive nephrosclerosis, a form of chronic kidney disease.

Other names: 温肾化痰祛瘀方

Beyond the preview

Go deeper on wenshen-huatan-quyu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on wenshen-huatan-quyu.

Explore the full profile